"This ruling is a setback for patients that will hinder medical progress for diseases withouteffectivetreatment options, " said Ranjit Shahani, vice-chairman and managing director of Novartis India.
The more efficient and effective approach is to allow profitable companies to return excess capital to their shareholders without subjecting those dividends to discriminatory tax treatment.